{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Drug Updates and Approvals: 2017 in Review

Activity Steps

Purpose of Activity

To acquaint clinicians with several new primary care drugs approved by the FDA during the first half of 2017.

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Identify indications and contraindications for each drug discussed.
  2. Discuss administration, adverse reactions, and monitoring requirements related to the medications.
Price: $17.95


  • ANCC 1.5 CH / 1.5 APH
  • DC - BON 1.5 CH
  • FL - BON 1.5 CH
  • GA - BON 1.5 CH

Lippincott Professional Development is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, and Georgia Board of Nursing, #50-1223.

Awarded Advanced Pharmacology Hours

Test Code: NP1217A
Published: Dec 2017
Expires: 12/3/2021
Required Passing Score: 13/18 (72%)
Authors: Geoffrey Mospan, PharmD, BCPS; Cortney Mospan, PharmD, BCACP, BCGP; Shayna Vance; Alyssa Bradshaw; Kalyn Meosky; Kirklin Bowles